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Abstract 
Purpose: To develop an extended-release formulation of domperidone using a blend of Raphia hookeri 
gum and hydroxypropyl methylcellulose as tablet matrix. 
Methods: Tablets (400 mg) containing 30 mg domperidone (DPD) were formulated using binary 
mixtures of hydroxypropyl methylcellulose (HPMC) and Raphia hookeri gum (RHG) as matrix former; 
and microcrystalline cellulose (MCC) as direct compression excipient. The proportions of the matrix 
formers (40 % of tablet weight) was varied as 100:0, 75:25, 50:50, 25:75 and 0:100. The composition of 
the matrix former was also kept constant (50:50) while MCC was varied as 40, 30, 20 and 10 %. The 
tablets were evaluated for compact density, tensile strength, friability and drug release over 24 h. 
Results: The tensile strength of tablets decreased while their friability increased with increase in the 
proportion of RHG. A similar trend was observed with decrease in the concentration of MCC. Tablets 
containing RHG alone as matrix former and 40 % MCC as direct compression excipient had tensile 
strength of 0.95 MNm-2, friability of 1.07 % and cumulative drug release of 83.2 % over a period of 24 h. 
Tablets containing equal proportions of HPMC and RHG as matrix former had the best release 
properties of 95.0 % over a period of 24 h. 
Conclusion: RHG is comparable with HPMC in terms of extending the release of domperidone for a 
once daily administration. A suitable combination of the two polymers for use as a matrix former is 
superior to either of the individual polymers.  
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Tablets are the most popular pharmaceutical 
dosage forms having numerous advantages. 
These advantages include: ease and low cost of 
production, high stability, possibility of masking 
objectionable odour and bitter taste, ease of 
product identification, portability, precise dosing 
and ease of administration [1]. Another major 
advantage of tableting is the possibility of 
formulation as controlled release systems [2]. 
Such systems are useful for modifying duration 
of action, reducing frequency of administration 
and increasing therapeutic effect; and thus 
increasing patients’ compliance and optimizing 
therapeutic outcome [3]. The major challenge is 
the need for appropriate excipients for such 
delivery systems [4]. 
 
Raphia hookeri (Family: Palmae) is the largest 
palm in Africa and is widely distributed in lowland 
swamps of western and central sub-regions of 
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the continent [5]. The work of Olorunsola et al. [6] 
showed that the exudates of the plant contain 28 
%  gum and that 3 %  dispersion of the 
gum has pH of 4.09 and viscosity of 208.60 
mPa.s (measured using spindle 2 at 60 rpm and 
27.4 oC). Raphia hookeri gum has been 
evaluated for binding properties in conventional 
tablets at concentration of 1 – 5 %  in 
comparison with gelatin using wet granulation 
method [7]. It was observed that granules of 
formulations containing gelatin had better flow 
properties. It was also observed that tablets 
containing RHG were characterized by better 
mechanical properties, longer disintegration time 
and slower dissolution rate. This is a pointer to 
the suitability of the polymer for an extended 
delivery. However, exploitation of this polymer for 
such purpose was not obtainable from available 
literature.  
 
Domperidone is a specific blocker of dopamine 
receptor. It is a prokinetic that speeds up 
gastrointestinal movement [8]. It is used for the 
management of dyspepsia, epigastric pain and 
heart burn. It is also used as an antiemetic [8]. It 
is a weakly basic drug with good solubility in 
acidic medium [9]. The elimination half-life is 5 - 
7 h, the oral bioavailability is 13 - 17 % and the 
adult dose is 10 mg three times daily [9]. These 
pharmacokinetic parameters prompted the 
development of an extended release formulation 
of the drug using suitable polymers to reduce the 
frequency of administration of the drug. This 
study was aimed at formulating an extended 
release system of the drug (using a blend of 
Raphia hookeri gum and hydroxypropyl 






Domperidone was obtained as a gift from May 
and Baker PLC Lagos, Nigeria. Hydroxypropyl 
methylcellulose (Spectracel 15E, low molecular 
weight) was a gift from Sensient, St. Louis, USA. 
Microcrystalline cellulose was purchased from 
E.merk, Darmstadt; while lactose was purchased 
from Riedel De Haenac seelze, Hannover. 
Raphia hookeri gum was obtained from the 
previous work of Majekodunmi and Makper [7]. 




A sample each of domperidone, Raphia hookeri 
gum and a physical mixture of the two materials 
was prepared in a KBr disk. The FTIR spectra 
were recorded over a scanning range of 350 to 
4000 cm-1 using a spectrophotometer (Shimadzu 
Corporation, model 8400S, Kyoto-Japan).   
 
Preparation of extended-release tablets of 
domperidone 
 
Domperidone tablets were formulated based on 
the formula in Table 1. All the ingredients as 
specified for each formulation (F1 to F8) were 
weighed and then mixed thoroughly. Flat 400 mg 
tablets were produced by direct compression 
using F3 single station tableting machine 
(Cadmach Machinery Co. PVT., India) fitted with 
12.50 mm punches. 
 
Evaluation of tablet formulations  
 
Weight and dimensions 
 
Five (5) tablets from each batch were weighed 
individually using an analytical balance (Mettler, 
Germany). The dimensions (diameter and 
thickness) of the tablets were also determined 
using digital vernier caliper. 
 
Crushing strength  
 
The crushing strength of the five selected tablets 
per batch was determined using Monsanto 
hardness tester [10].  The crushing strength was 
taken as the force required to break a tablet 
when the pressure generated by the coiled 




Table 1: Tablet composition 
 
Ingredient (mg/tablet) F1 F2 F3 F4 F5 F6 F7 F8 
Domperidone 30 30 30 30 30 30 30 30 
Hydroxypropyl methylcellulose 160 120 80 40 0 80 80 80 
Raphia hookeri gum 0 40 80 120 160 80 80 80 
Lactose 50 50 50 50 50 90 130 170 
Microcrystalline cellulose 160 160 160 160 160 120 80 40 
Total 400 400 400 400 400 400 400 400 
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Compact density  
 
Tablet density (D) was calculated using the 
mass, diameter and thickness of the five tablets 
selected randomly from each batch and by 
applying Eq 1 [11]. 
 
D = m/ r2h………….… (1) 
 





Tensile strength (T) was calculated using the 
crushing strength, diameter and thickness of the 
five tablets from each batch and by applying Eq 2 
[12]. 
 
T = 2F/ dt………….... (2) 
 
where F is the crushing strength, d the diameter 




Ten tablets were dedusted, weighed together 
and then subjected to abrasion test in a frabilator 
(Erweka, Germany) operated at 25 rpm for 4 min.  
The tablets were dedusted again and then 
reweighed together [10].  The difference in 
weight was determined and the friability value 
was calculated as the ratio of difference in weight 




In-vitro dissolution test for the tablets was carried 
out using the basket method in USP dissolution 
test apparatus. The tablet was placed in a wire 
mesh basket suspended in a dissolution medium 
of 900 ml 0.1 N HCl maintained at temperature of 
37 ± 1 oC. The basket was rotated at a speed of 
50 rpm and the experiment was allowed for 24 h. 
Aliquots (10 ml) was withdrawn at 1.5, 3, 6, 9, 12, 
18 and 24 h. Each sample was filtered through 
Whatman Grade No. 4 filter paper and the 
absorbance was taken at 287 nm using UV 
spectrophotometer (Jenway, England). The 
cumulative percent drug released was calculated 
using Eq 3. A graph of cumulative percent drug 
released was plotted against time [10]. 
 
R (%) =   x 100% ……………. (3) 
 
where R is cumulative percent drug released, A 
is the absorbance of solution of drug released at 
the specified time, V is the volume of dissolution 
medium, S is the slope of the calibration curve of 
absorbance and D is the amount of drug per 
tablet. 
 
Statistical analysis   
 
Data are expressed as mean ± standard 
deviation (SD). The analysis was carried out 
using one-way analysis of variance followed by 
multiple comparison tests with the aid of 
GraphPad Instat-3 tool. Significance of difference 




Fourier transform infrared (FTIR) spectra 
 
The FTIR spectra of domperidone, Raphia 
hookeri gum and that of their physical mixture 
are shown in Figure 1. The spectrum of 
domperidone showed twenty-two identifiable 
peaks, that of Raphia hookeri gum showed nine 
identifiable peaks while that of the physical 
mixture showed fifteen identifiable peaks. 
 
Effect of polymer ratio on physical properties 
of tablets 
 
The effect of polymer ratio of matrix former 
(HPMC : RHG) on compact density, tensile 
strength and friability of tablets is shown in Table 
2. There was a significant difference in the 
compact density of F1 and those of other 
formulations (F2, F3, F4 and F5). There were no 
significant differences in the compact densities of 
F2, F3, F4 and F5. The tensile strength 
decreased with increase in the proportion of 
RHG in the matrix former and the values were 
significantly different (p < 0.05). Formulations F1, 
F2 and F3 had friability values less than 1 % 
while F4 and F5 had values greater than 1 %. 
 
Effect of polymer ratio on drug release 
 
The plots of cumulative percent drug released 
versus time for F1, F2, F3, F4 and F5 are shown 
in Figure 2. The cumulative percent drug 
released at every time increased from F1 down 
to F4 (that is, with increase in the proportion of 
RHG in the matrix former). The trend changed in 
the case of F5; the cumulative percent drug 
release at 24 h (83.2 %) being lower than for F3 
and F4. Formulation F4 brought forth complete 
drug release within 12 h. 
 
Effect of MCC concentration on physical 
properties of tablets 
 
The effect of concentration of microcrystalline 
cellulose on compact density, tensile strength 
and friability of tablet is shown in Table 3. There 
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were no significant differences in the compact 
density of the four formulations. Also, there were 
no significant differences in the tensile strength 
of F6, F7 and F8 but formulation F3 has a 
significantly higher tensile strength. The values of 
tensile strength decreased with decrease in the 
concentration of MCC. The friability of tablet also 
increased with decrease in the concentration of 





Figure 1: FTIR spectra of (a) domperidone (b) Raphia hookeri gum (c) physical mixture of domperidone and 
Raphia hookeri gum 
 
Table 2: Effect of polymer ratio on tablet properties 
 
 Ratio of matrix formers Compact density Tensile strength Friability 
Batch HPMC:RHG (g/cm3) (MN/m2) (%) 
F1 100:0 1.39±0.03 1.76±0.38 0.63±0.05 
F2 75:25 1.29±0.01 1.53±0.19 0.67±0.00 
F3 50:50 1.29±0.01 1.21±0.32 0.90±0.02 
F4 25:75 1.29±0.01 1.03±0.14 1.04±0.00 
F5 0:100 1.28±0.00 0.95±0.13 1.07±0.00 
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Figure 2: Dissolution profile of tablets. Key: F1 (◊), F2 (■), F3 (▲), F4 (X), F5 (O) 
 
Table 3: Effect of concentration of MCC on physical properties of tablets  
 
 Concentration of MCC Compact density Tensile strength Friability 
Batch (%) (g/cm3) (MN/m2) (%) 
F3 40 1.29±0.01 1.21±0.32 0.90±0.02 
F6 30 1.29±0.01 0.93±0.16 1.32±0.11 
F7 20 1.28±0.01 0.89±0.03 1.36±0.15 
F8 10 1.28±0.02 0.68±0.11 1.55±0.03 
 
 
Figure 3: Dissolution profile of domperidone tablets. Key: F3 (▲), F6 (◊), F7 (■), F8 (X) 
 
Effect of MCC concentration on drug release 
 
The plots of cumulative percent drug released 
versus time for formulations F3, F6, F7 and F8 
are shown in Figure 3. The rate of drug release 
and the total drug release at 24 h followed the 




The decrease in the number of peaks in the 
spectrum of the physical mixture can be ascribed 
to superimposition of peaks and not formation of 
a new compound. Also, the retention of all the 
major peaks of domperidone in the spectrum of 
the physical mixture shows that there was no 
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adverse interaction between the drug and the 
gum. Therefore, Raphia hookeri gum is 
compatible with the drug [13]. 
 
The characteristics of formulations F1, F2, F3, F4 
and F5 illustrate the effect of the composition of 
the matrix former on domperidone tablets. Tablet 
formulation containing hydroxypropyl 
methylcellulose alone as a matrix former (F1) 
was characterized by the highest compact 
density. The tablets from this formulation are 
relatively smaller in size since density is inversely 
related to volume. The other formulations (F2, 
F3, F4 and F5) are not significantly different in 
size since there was no significant difference in 
their density.  Hence, using a blend of RHG and 
HPMC as tablet matrix for domperidone will 
produce tablet of bigger size compared to using 
HPMC alone. 
 
The presence of RHG caused a decrease in 
tensile strength of tablets. Tensile strength is a 
measure of strength of tablets and it is influenced 
by the degree of plastic deformation experienced 
by a polymer [14]. Hence, the degree of plastic 
deformation experienced by RHG could be less 
than that of HPMC. Tensile strength as a 
parameter of tablet strength is absolute as it 
takes into consideration the thickness and 
diameter of the tablet. 
 
Friability of less than 1 % is required for a tablet 
to pass friability test [10, 15]. Formulations F1, 
F2 and F3 passed the test for friability while 
formulations F4 and F5 failed. Friability is a 
measure of tablet weakness and it shows the 
susceptibility of tablet to abrasion as it moves 
from the point of production down to point of 
administration. The friability values show that the 
tablet weakness increases with increase in the 
proportion of RHG in the matrix former. 
 
Out of the five formulations, F1 brought forth the 
lowest drug release at 24 h. Hence, the 
formulation is the most effective in sustaining the 
drug release. However, it gave incomplete drug 
release as at the 24 h. The cumulative percent 
drug release increased with increase in the 
proportion of RHG in the matrix former. 
Formulation F4 brought forth almost complete 
drug release within 12 h and cannot sustain the 
release for a 24 h period. Formulation F3 
(containing HPMC and RHG in ratio 1 : 1 as 
matrix former) gave about complete drug release 
at 24 h. The work of Sakurai et al. [16] showed 
that combination of HPMC with co-polyvidone or 
polyvinylpyrrolidone led to increase stability and 
solubility owing to solid dispersion effect on each 
other. Thus, the increased drug release when 
HPMC and RHG were combined could be 
attributed to solid dispersion effect on each other. 
The suitability of combination of these two 
polymers can be linked to two factors namely: 
ability of both polymers to sustain drug release 
and the solid dispersion effect of the two 
polymers to improve extent of drug release.  
 
Raphia hookeri gum alone as a matrix former 
(F5) brought forth cumulative percent drug 
release which is comparable with that of HPMC. 
Hence, the polymer is comparable with HPMC in 
sustaining the release of domperidone over a 24 
h period. It is suitable for a once daily formulation 
with total drug release of 83.2 %. 
 
The characteristics of formulations F3, F6, F7 
and F8 reflect the effect of concentration of MCC 
on domperidone tablets. The concentration of 
MCC had no significant effect on the compact 
density. Therefore, the concentration of the direct 
compression excipient has no significant effect 
on the tablet size since there is an inverse 
relationship between volume and density as 
earlier stated. 
 
The tensile strength decreased as the 
concentration of the direct compression excipient 
was decreased. This observation was not 
unexpected because the MCC was incorporated 
to provide the binding effect. It can be inferred 
that even though the concentration of the direct 
compression excipient has no significant effect 
on the compactness of tablet, it has a significant 
effect on its coherence. 
 
As earlier stated, a friability of less than 1 % is 
expected for a tablet to pass friability test [10, 
15]. Only F3 (which contains 40 % MCC) passed 
the test. Since both tablet strength (tensile 
strength) and weakness (friability) must be 
assessed to ensure acceptable mechanical 
properties of tablet, MCC at the concentration of 
40 % produced tablet with the best mechanical 
property. 
 
The four formulations (F3, F6, F7 and F8) were 
able to sustain release of domperidone over a 
period of 24 h. However, the extent of drug 
release decreased with decrease in the 
concentration of MCC. The high extent of drug 
delivery at high concentration of MCC can be 
attributed to the disintegration effect of the 
polymer [17]. It can also be attributed to better 
solid dispersion effect of the three polymers 




Raphia hookeri gum is comparable to HPMC as 
a matrix former in sustaining drug release over a 
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period of 24 h although it is characterized by 
reduced tablet strength. A combination of the two 
polymers as a matrix former is suitable for 
enhancing the extent of drug release. Hence, this 
combination can be further developed as a 
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